Core Points - *ST San Sheng reached the daily limit of 5.11 yuan, with a rise of 4.96%, and a total market value of 2.104 billion yuan on November 24, 2025 [1] - The company’s restructuring plan has been approved by the court, allowing it to avoid direct bankruptcy liquidation, with a high approval rate from creditors [2] - The introduction of strategic investor Jiheng Group will provide at least 200 million yuan in cash flow support over three years, enhancing the company's core competitiveness in the pharmaceutical sector [2] - The overall performance of the ST sector was active on the same day, contributing to *ST San Sheng's stock price increase, supported by net inflows from major funds [2] - Technical indicators show a bullish trend for the stock, with MACD forming a golden cross and the price breaking through short-term moving average resistance [2]
*ST三圣2025年11月24日涨停分析:重整计划获批+引入投资人+聚焦医药主业